Updated Jul 16, 2026
BREITMEYER JAMES B has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
James B. Breitmeyer is a corporate executive known for his role as a director at Vaxart, Inc., a biotechnology company focused on developing oral vaccines. His experience in the biotech sector contributes to the company's strategic direction and governance.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-02 | VXRT | Vaxart, Inc. | A — Grant or award | 78.8K | $0.00 |
James B. Breitmeyer is a corporate executive known for his role as a director at Vaxart, Inc., a biotechnology company focused on developing oral vaccines. His experience in the biotech sector contributes to the company's strategic direction and governance.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BREITMEYER JAMES B profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.